Enhanced nose-to-brain delivery of numerous other peptides is also desirable for conditions like depression, Parkinson’s disease and Post-Traumatic Stress Disorder, with oxytocin receiving particular attention for Autism Spectrum Disorders and schizophrenia [12]. This evidence concerns the gene OXT and autism spectrum disorder.